Free shipping on all U.S. orders over $250 · Local pickup available in Morgan Hill, CA
PureLab Performancepurelabperformance.com
Research compoundCognitive & Mood ResearchIn stock

Semax

Semax is a synthetic heptapeptide built from the ACTH(4-7) fragment extended with Pro-Gly-Pro. Published research is mostly rat and mouse work from a small group of Russian laboratories; no peer-reviewed human trials were verified for this page.

Evidence: preclinical · Mostly rat and mouse studies

At a glance

Class
Synthetic ACTH(4-7)PGP heptapeptide
Developer
No Western pharmaceutical developer; research led by Russian academic institutes
FDA status
Not FDA-approved
Human data
No peer-reviewed human trials verified for this page
Animal / lab data
Rat brain gene- and protein-expression studies; mouse receptor-binding and transgenic-model studies

Where it’s been studied

1
  • 1BrainHippocampal BDNF, rat (2006); ischemia-reperfusion (tMCAO) model, rat (2020, 2021); NMDA binding, mouse (2023); transgenic amyloid model, mouse (2025)

Mechanism studied

In rat hippocampus, a single Semax administration raised BDNF protein about 1.4-fold and trkB mRNA about 2-fold [3]. In a rat ischemia-reperfusion (tMCAO) model, researchers measured 394 genes changing expression at 24 h and lower phosphorylated JNK with higher phosphorylated CREB [1][2]. A melanocortin-receptor route has been proposed from the peptide's ACTH origin but is not established.

What the research shows

StudyModelReported resultSource
Semax and BDNF/trkB in rat hippocampus [3]Rat
Healthy rats, single administration, hippocampal tissue
BDNF protein rose up to ~1.4-fold, trkB phosphorylation ~1.6-fold, exon III BDNF mRNA ~3-fold and trkB mRNA ~2-fold.Peer-reviewed
2006 (PMID 16996037)
Transcriptome after ischemia-reperfusion [1]Rat
Ischemia-reperfusion model (tMCAO, 90 min), male Wistar rats, RNA-seq n=3 per group
No gene changes at 4.5 h; 394 genes changed at 24 h (191 up, 203 down), many in the opposite direction to the model's own changes.Peer-reviewed
Genes 2020
Brain protein profile after ischemia-reperfusion [2]Rat
Ischemia-reperfusion model (tMCAO, 90 min), male Wistar rats, n=5-7 per group, 24 h
Subcortical pJNK fell >1.5-fold and pCREB rose >1.5-fold vs model controls; cortical Fos mRNA fell 2.6-fold.Peer-reviewed
Int J Mol Sci 2021
NMDA glycine-site binding in two mouse strains [4]Mouse
BALB/c and C57Bl/6 mice, subchronic administration, radioligand binding in cortex and hippocampus
Semax administration lowered cortical glycine-site binding in both strains (see publication) and raised hippocampal binding 95% in BALB/c mice.Peer-reviewed
Neirokhimiya 2023
Semax in a transgenic amyloid mouse model [5]Mouse
APPswe/PS1dE9/Blg transgenic mice
Researchers reported behavioral-test and histology measurements; abstract gives no effect sizes.Peer-reviewed
Acta Naturae 2025

Human trials are listed for research context only; outcomes are reported in the linked publications. Animal and lab results do not establish effects in humans.

Verified by third-party testing

CertificatePosted on the product page
TestingIndependent, third-party

Research-grade supply

PureLab supplies Semax for laboratory research. Lot-specific certificates of analysis are posted on the product page as they are issued.

View research-grade Semax

More in Cognitive & Mood Research

Sources

  1. Filippenkov IB et al. (2020). doi:10.3390/genes11060681 Source
  2. Sudarkina OY et al. (2021). doi:10.3390/ijms22126179 Source
  3. Published source (2006) Source
  4. Vasileva EV et al. (2023). doi:10.31857/S1027813323020176 Source
  5. Radchenko AI et al. (2025). doi:10.32607/actanaturae.27808 Source
For research use only. Not for human or veterinary use. Not a drug, food or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. This library summarizes published research for educational purposes. PureLab Performance Inc.